A new insight into oxidative stress is based on oxidative deoxyribonucleic acid (DNA) damage. DNA is the pivotal biopolymer for life and health. Arterial hypertension (HT) is a globally common disease and a major risk factor for numerous cardiovascular (CV) conditions and non-cardiac complications, making it a significant health and socio-economic problem. The aetiology of HT is multifactorial. Oxidative stress is the main driver. Oxidative DNA damage (oxidised guanosine (8OHdG), strand breaks (SSBs, DSBs)) seems to be the crucial and initiating causal molecular mechanism leading to HT, acting through oxidative stress and the resulting consequences (inflammation, fibrosis, vascular remodelling, stiffness, thickness, and endothelial dysfunction). In light of the current European Society of Cardiology (ESC) guidelines with defined gaps in the evidence, this manuscript, for the first time, (1) summarizes evidence for oxidative DNA damage in HT and other CV risk factors, (2) incorporates them into the context of known mechanisms in HT genesis, (3) proposes the existing concept of HT genesis innovatively supplemented with oxidative DNA damage, and (4) mentions consequences such as promising new targets for the treatment of HT (DNA damage response (DDR) pathways).

3rd Department of Internal Medicine Gerontology and Metabolism Medical Faculty in Hradec Králové University Hospital Hradec Králové Charles University Prague 50003 Hradec Králové Czech Republic

Department of Cardiology and Internal Medicine Profi Kardio s r o 50801 Hořice Czech Republic

Department of Internal Medicine 1 Cardiology University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc 77900 Olomouc Czech Republic

Zobrazit více v PubMed

McEvoy J.W., McCarthy C.P., Bruno R.M., Browers S., Canavan M.D., Ceconi C., Christodorescu R.M., Daskalopoulou S.S., Ferro C.J., Gerdts E., et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur. Heart J. 2024;45:3912–4018. doi: 10.1093/eurheartj/ehae178. PubMed DOI

Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018;39:3021–3104. doi: 10.1093/eurheartj/ehy339. PubMed DOI

Mazzolai L., Teixido-Tura G., Lanzi S., Boc V., Bossone E., Brodmann M., Bura-Rivière A., De Backer J., Deglise S., Corte A.D., et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur. Heart J. 2024;45:3538–3700. doi: 10.1093/eurheartj/ehae179. PubMed DOI

Vrints C., Andreotti F., Koskinas K.C., Rossello X., Adamo M., Ainslie J., Banning A.P., Budaj A., Buechel R.R., Chiariello G.A., et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur. Heart J. 2024;45:3415–3537. doi: 10.1093/eurheartj/ehae177. PubMed DOI

Gelder I.C.V., Rienstra M., Bunting K.V., Casado-Arroyo R., Caso V., Crijns H.J.G.M., Potter T.J.R.D., Dwight J., Guasti L., Hanke T., et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2024;45:3314–3414. doi: 10.1093/eurheartj/ehae176. PubMed DOI

McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2023;44:3627–3639. doi: 10.1093/eurheartj/ehad195. PubMed DOI

Marx N., Federici M., Schütt K., Müller-Wieland D., Ajjan R.A., Antunes M.J., Christodorescu R.M., Crawford C., Di Angelantonio E., Eliasson B., et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. 2023;44:4043–4140. doi: 10.1093/eurheartj/ehad192. PubMed DOI

Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., Bäck M., Benetos A., Biffi A., Boavida J.M., Capodanno D., et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021;42:3227–3337. doi: 10.1093/eurheartj/ehab484. PubMed DOI

Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020;41:111–188. doi: 10.1093/eurheartj/ehz455. PubMed DOI

Griendling K.K., Camargo L.L., Rios F.J., Alves-Lopes R., Montezano A.C., Touyz R.M. Oxidative Stress and Hypertension. Circ. Res. 2021;128:993–1020. doi: 10.1161/CIRCRESAHA.121.318063. PubMed DOI PMC

Touyz R.M., Rios F.J., Alves-Lopes R., Neves K.B., Camargo L.L., Montezano A.C. Oxidative Stress: A Unifying Paradigm in Hypertension. Can. J. Cardiol. 2020;36:659–670. doi: 10.1016/j.cjca.2020.02.081. PubMed DOI PMC

Camargo L.L., Harvey A.P., Rios F.J., Tsiropoulou S., Da Silva R.N.O., Cao Z., Graham D., McMaster C., Burchmore R.J., Hartley R.C., et al. Vascular Nox (NADPH Oxidase) Compartmentalization, Protein Hyperoxidation, and Endoplasmic Reticulum Stress Response in Hypertension. Hypertension. 2018;72:235–246. doi: 10.1161/HYPERTENSIONAHA.118.10824. PubMed DOI PMC

Camargo L.L., Wang Y., Rios F.J., McBride M., Montezano A.C., Touyz R.M. Oxidative Stress and Endoplasmic Reticular Stress Interplay in the Vasculopathy of Hypertension. Can. J. Cardiol. 2023;39:1874–1887. doi: 10.1016/j.cjca.2023.10.012. PubMed DOI

Rotariu D., Babes E.E., Tit D.M., Moisi M., Bustea C., Stoicescu M., Radu A.F., Vesa C.M., Behl T., Bungau A.F., et al. Oxidative stress—Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders. Biomed. Pharmacother. 2022;152:113238. doi: 10.1016/j.biopha.2022.113238. PubMed DOI

Nocella C., D’Amico A., Cammisotto V., Bartimoccia S., Castellani V., Loffredo L., Marini L., Ferrara G., Testa M., Motta G., et al. Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies. Antioxidants. 2023;12:429. doi: 10.3390/antiox12020429. PubMed DOI PMC

Caminiti R., Carresi C., Mollace R., Macrì R., Scarano F., Oppedisano F., Maiuolo J., Serra M., Ruga S., Nucera S., et al. The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension. Front. Cardiovasc. Med. 2024;11:1345218. doi: 10.3389/fcvm.2024.1345218. PubMed DOI PMC

Krzemińska J., Wronka M., Młynarska E., Franczyk B., Rysz J. Arterial Hypertension-Oxidative Stress and Inflammation. Antioxidants. 2022;11:172. doi: 10.3390/antiox11010172. PubMed DOI PMC

Panda P., Verma H.K., Lakkakula S., Merchant N., Kadir F., Rahman S., Jeffree M.S., Lakkakula B.V.K.S., Rao P.V. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases. Oxid. Med. Cell. Longev. 2022;24:9154295. doi: 10.1155/2022/9154295. PubMed DOI PMC

Qin H., Shen L., Xu D. Association of composite dietary antioxidant index with mortality in adults with hypertension: Evidence from NHANES. Front. Nutr. 2024;11:1371928. doi: 10.3389/fnut.2024.1371928. PubMed DOI PMC

Balan A.I., Halațiu V.B., Scridon A. Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation. Antioxidants. 2024;13:117. doi: 10.3390/antiox13010117. PubMed DOI PMC

Dang J.Y., Zhang W., Chu Y., Chen J.H., Ji Z.L., Feng P. Downregulation of salusins alleviates hypertrophic cardiomyopathy via attenuating oxidative stress and autophagy. Eur. J. Med. Res. 2024;29:109. doi: 10.1186/s40001-024-01676-z. PubMed DOI PMC

Meng Q., Su C.H. The Impact of Physical Exercise on Oxidative and Nitrosative Stress: Balancing the Benefits and Risks. Antioxidants. 2024;13:573. doi: 10.3390/antiox13050573. PubMed DOI PMC

Shafiq M., Lone Z.R., Abdulkareem A.O., Kaur G., Navya S., Singh H., Jagavelu K., Hanif K. Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension. Pulm. Pharmacol. Ther. 2023;80:102200. doi: 10.1016/j.pupt.2023.102200. PubMed DOI

Hazuková R., Řezáčová M., Kočí J., Čermáková E., Pleskot M. Severe deoxyribonucleic acid damage after out-of-hospital cardiac arrest in successfully resuscitated humans. Int. J. Cardiol. 2016;207:33–35. doi: 10.1016/j.ijcard.2016.01.046. PubMed DOI

Hazukova R., Rezacova M., Köhlerová R., Tomek T., Cermáková E., Kocí J., Pleskot M. Comet assay in evaluating deoxyribonucleic acid damage after out-of-hospital cardiac arrest. Anatol. J. Cardiol. 2017;18:31–38. doi: 10.14744/AnatolJCardiol.2017.7578. PubMed DOI PMC

Hazukova R., Rezacova M., Pleskot M., Zadak Z., Cermakova E., Taborsky M. DNA damage and arterial hypertension. A systematic review and meta-analysis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2024;168:15–24. doi: 10.5507/bp.2023.044. PubMed DOI

Hazuková R. Arterial hypertension and significant DNA damage—From cell lines to patients. Cor Vasa. 2024;66:506–511. doi: 10.33678/cor.2024.075. DOI

Huang R., Zhou P.K. DNA damage repair: Historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct. Target. Ther. 2021;6:254. doi: 10.1038/s41392-021-00648-7. PubMed DOI PMC

Machacova Z., Chroma K., Lukac D., Protivankova I., Moudry P. DNA polymerase α-primase facilitates PARP inhibitor-induced fork acceleration and protects BRCA1-deficient cells against ssDNA gaps. Nat. Commun. 2024;15:7375. doi: 10.1038/s41467-024-51667-1. PubMed DOI PMC

Meloche J., Pflieger A., Vaillancourt M., Paulin R., Potus F., Zervopoulos S., Graydon C., Courboulin A., Breuils-Bonnet S., Tremblay E., et al. Role for DNA damage signaling in pulmonary arterial hypertension. Circulation. 2014;129:786–797. doi: 10.1161/CIRCULATIONAHA.113.006167. PubMed DOI

Zhang D., Hu X., Li J., Liu J., Baks-te Bulte L., Wiersma M., Malik N.U., van Marion D.M.S., Tolouee M., Hoogstra-Berends F., et al. DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation. Nat. Commun. 2019;10:1307. doi: 10.1038/s41467-019-09014-2. PubMed DOI PMC

Wang X., Yu J., Wang J. Neural Tube Defects and Folate Deficiency: Is DNA Repair Defective? Int. J. Mol. Sci. 2023;24:2220. doi: 10.3390/ijms24032220. PubMed DOI PMC

Kornepati A.V.R., Rogers C.M., Sung P., Curiel T.J. The complementarity of DDR, nucleic acids and anti-tumour immunity. Nature. 2023;619:475–486. doi: 10.1038/s41586-023-06069-6. PubMed DOI

Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998;273:5858–5868. doi: 10.1074/jbc.273.10.5858. PubMed DOI

Rahmanian N., Shokrzadeh M., Eskandani M. Recent advances in γH2AX biomarker-based genotoxicity assays: A marker of DNA damage and repair. DNA Repair. 2021;108:103243. doi: 10.1016/j.dnarep.2021.103243. PubMed DOI

Chappidi N., Quail T., Doll S., Vogel L.T., Aleksandrov R., Felekyan S., Kühnemuth R., Stoynov S., Seidel C.A.M., Brugués J., et al. PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA ends. Cell. 2024;187:945–961.e18. doi: 10.1016/j.cell.2024.01.015. PubMed DOI

Wei X., Zhou F., Zhang L. PARP1-DNA co-condensation: The driver of broken DNA repair. Signal Transduct. Target. Ther. 2024;9:135. doi: 10.1038/s41392-024-01832-1. PubMed DOI PMC

Lee W.H., Nguyen P.K., Fleischmann D., Wu J.C. DNA damage-associated biomarkers in studying individual sensitivity to low-dose radiation from cardiovascular imaging. Eur. Heart J. 2016;37:3075–3080. doi: 10.1093/eurheartj/ehw206. PubMed DOI PMC

Knuuti J., Saraste A., Kallio M., Minn H. Is cardiac magnetic resonance imaging causing DNA damage? Eur. Heart J. 2013;34:2337–2339. doi: 10.1093/eurheartj/eht214. PubMed DOI

Santovito D., Steffens S. DNA damage and extranuclear DNA sensors: A dangerous duo in atherosclerosis. Eur. Heart J. 2021;42:4349–4351. doi: 10.1093/eurheartj/ehab300. PubMed DOI

Ganapathy V., Manyanga J., Brame L., McGuire D., Sadhasivam B., Floyd E., Rubenstein D.A., Ramachandran I., Wagener T., Queimado L. Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage. PLoS ONE. 2017;12:e0177780. doi: 10.1371/journal.pone.0177780. PubMed DOI PMC

Rankin G.D., Wingfors H., Uski O., Hedman L., Ekstrand-Hammarström B., Bosson J., Lundbäck M. The toxic potential of a fourth-generation E-cigarette on human lung cell lines and tissue explants. J. Appl. Toxicol. 2019;39:1143–1154. doi: 10.1002/jat.3799. PubMed DOI

Hang B., Sarker A.H., Havel C., Saha S., Hazra T.K., Schick S., Jacob P., 3rd, Rehan V.K., Chenna A., Sharan D., et al. Thirdhand smoke causes DNA damage in human cells. Mutagenesis. 2013;28:381–391. doi: 10.1093/mutage/get013. PubMed DOI PMC

Messner B., Frotschnig S., Steinacher-Nigisch A., Winter B., Eichmair E., Gebetsberger J., Schwaiger S., Ploner C., Laufer G., Bernhard D. Apoptosis and necrosis: Two different outcomes of cigarette smoke condensate-induced endothelial cell death. Cell Death Dis. 2012;3:e424. doi: 10.1038/cddis.2012.162. PubMed DOI PMC

Ganapathy V., Ramachandran I., Rubenstein D.A., Queimado L. Detection of in vivo DNA damage induced by very low doses of mainstream and sidestream smoke extracts using a novel assay. Am. J. Prev. Med. 2015;48((Suppl. S1)):S102–S110. doi: 10.1016/j.amepre.2014.08.017. PubMed DOI

Tanaka T., Huang X., Jorgensen E., Gietl D., Traganos F., Darzynkiewicz Z., Albino A.P. ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke. BMC Cell Biol. 2007;8:26. doi: 10.1186/1471-2121-8-26. PubMed DOI PMC

Li J., Huynh L., Cornwell W.D., Tang M.S., Simborio H., Huang J., Kosmider B., Rogers T.J., Zhao H., Steinberg M.B., et al. Electronic Cigarettes Induce Mitochondrial DNA Damage and Trigger TLR9 (Toll-Like Receptor 9)-Mediated Atherosclerosis. Arter. Thromb. Vasc. Biol. 2021;41:839–853. doi: 10.1161/ATVBAHA.120.315556. PubMed DOI PMC

Aoshiba K., Zhou F., Tsuji T., Nagai A. DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur. Respir. J. 2012;39:1368–1376. doi: 10.1183/09031936.00050211. PubMed DOI

Yao Q.H., Mei S.R., Weng Q.F., Zhang P.D., Yang Q., Wu C.Y., Xu G.W. Determination of urinary oxidative DNA damage marker 8-hydroxy-2′-deoxyguanosine and the association with cigarette smoking. Talanta. 2004;63:617–623. doi: 10.1016/j.talanta.2003.12.024. PubMed DOI

An A.R., Kim K.M., Park H.S., Jang K.Y., Moon W.S., Kang M.J., Lee Y.C., Kim J.H., Chae H.J., Chung M.J. Association between Expression of 8-OHdG and Cigarette Smoking in Non-small Cell Lung Cancer. J. Pathol. Transl. Med. 2019;53:217–224. doi: 10.4132/jptm.2019.02.20. PubMed DOI PMC

Yavuzer S., Yavuzer H., Cengiz M., Erman H., Demirdag F., Doventas A., Balci H., Erdincler D.S., Uzun H. The role of protein oxidation and DNA damage in elderly hypertension. Aging Clin. Exp. Res. 2016;28:625–632. doi: 10.1007/s40520-015-0464-7. PubMed DOI

Wolf F.I., Torsello A., Covacci V., Fasanella S., Montanari M., Boninsegna A., Cittadini A. Oxidative DNA damage as a marker of aging in WI-38 human fibroblasts. Exp. Gerontol. 2002;37:647–656. doi: 10.1016/S0531-5565(02)00005-0. PubMed DOI

Frisard M.I., Broussard A., Davies S.S., Roberts L.J., 2nd, Rood J., de Jonge L., Fang X., Jazwinski S.M., Deutsch W.A., Ravussin E., et al. Aging, resting metabolic rate, and oxidative damage: Results from the Louisiana Healthy Aging Study. J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:752–759. doi: 10.1093/gerona/62.7.752. PubMed DOI PMC

Pácal L., Varvařovská J., Rušavý Z., Lacigová S., Stětina R., Racek J., Pomahačová R., Tanhäuserová V., Kaňková K. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch. Physiol. Biochem. 2011;117:222–230. doi: 10.3109/13813455.2010.551135. PubMed DOI

Lewis-McDougall F.C., Ruchaya P.J., Domenjo-Vila E., Shin Teoh T., Prata L., Cottle B.J., Clark J.E., Punjabi P.P., Awad W., Torella D., et al. Aged-senescent cells contribute to impaired heart regeneration. Aging Cell. 2019;18:e12931. doi: 10.1111/acel.12931. PubMed DOI PMC

Ahuja G., Bartsch D., Yao W., Geissen S., Frank S., Aguirre A., Russ N., Messling J.E., Dodzian J., Lagerborg K.A., et al. Loss of genomic integrity induced by lysosphingolipid imbalance drives ageing in the heart. EMBO Rep. 2019;20:e47407. doi: 10.15252/embr.201847407. PubMed DOI PMC

Nakamura T., Hosoyama T., Kawamura D., Takeuchi Y., Tanaka Y., Samura M., Ueno K., Nishimoto A., Kurazumi H., Suzuki R., et al. Influence of aging on the quantity and quality of human cardiac stem cells. Sci. Rep. 2016;6:22781. doi: 10.1038/srep22781. PubMed DOI PMC

Giridharan V.V., Karupppagounder V., Arumugam S., Nakamura Y., Guha A., Barichello T., Quevedo J., Watanabe K., Konishi T., Thandavarayan R.A. 3,4-Dihydroxybenzalacetone (DBL) Prevents Aging-Induced Myocardial Changes in Senescence-Accelerated Mouse-Prone 8 (SAMP8) Mice. Cells. 2020;9:597. doi: 10.3390/cells9030597. PubMed DOI PMC

Canugovi C., Stevenson M.D., Vendrov A.E., Hayami T., Robidoux J., Xiao H., Zhang Y.Y., Eitzman D.T., Runge M.S., Madamanchi N.R. Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening. Redox Biol. 2019;26:101288. doi: 10.1016/j.redox.2019.101288. PubMed DOI PMC

Saheera S., Nair R.R. Accelerated decline in cardiac stem cell efficiency in Spontaneously hypertensive rat compared to normotensive Wistar rat. PLoS ONE. 2017;12:e0189129. doi: 10.1371/journal.pone.0189129. PubMed DOI PMC

Bloomer R.J., Fisher-Wellman K.H. Blood oxidative stress biomarkers: Influence of sex, exercise training status, and dietary intake. Gend. Med. 2008;5:218–228. doi: 10.1016/j.genm.2008.07.002. PubMed DOI

Braz M.G., Fávero Salvadori D.M. Influence of endogenous and synthetic female sex hormones on human blood cells in vitro studied with comet assay. Toxicol. Vitro. 2007;21:972–976. doi: 10.1016/j.tiv.2007.02.006. PubMed DOI

Esteves F., Amaro R., Silva S., Sánchez-Flores M., Teixeira J.P., Costa C. The impact of comet assay data normalization in human biomonitoring studies outcomes. Toxicol. Lett. 2020;332:56–64. doi: 10.1016/j.toxlet.2020.06.024. PubMed DOI

Hofer T., Karlsson H.L., Möller L. DNA oxidative damage and strand breaks in young healthy individuals: A gender difference and the role of life style factors. Free Radic Res. 2006;40:707–714. doi: 10.1080/10715760500525807. PubMed DOI

Slyskova J., Naccarati A., Polakova V., Pardini B., Vodickova L., Stetina R., Schmuczerova J., Smerhovsky Z., Lipska L., Vodicka P. DNA damage and nucleotide excision repair capacity in healthy individuals. Environ. Mol. Mutagen. 2011;52:511–517. doi: 10.1002/em.20650. PubMed DOI

Winkelbeiner N., Wandt V.K., Ebert F., Lossow K., Bankoglu E.E., Martin M., Mangerich A., Stopper H., Bornhorst J., Kipp A.P., et al. A Multi-Endpoint Approach to Base Excision Repair Incision Activity Augmented by PARylation and DNA Damage Levels in Mice: Impact of Sex and Age. Int. J. Mol. Sci. 2020;21:6600. doi: 10.3390/ijms21186600. PubMed DOI PMC

Wu L.L., Chiou C.C., Chang P.Y., Wu J.T. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta. 2004;339:1–9. doi: 10.1016/j.cccn.2003.09.010. PubMed DOI

Moller P., Wallin H., Holst E., Knudsen L.E. Sunlight-induced DNA damage in human mononuclear cells. FASEB J. 2002;16:45–53. doi: 10.1096/fj.01-0386com. PubMed DOI

Orlando P., Silvestri S., Galeazzi R., Antonicelli R., Marcheggiani F., Cirilli I., Bacchetti T., Tiano L. Effect of ubiquinol supplementation on biochemical and oxidative stress indexes after intense exercise in young athletes. Redox Rep. 2018;23:136–145. doi: 10.1080/13510002.2018.1472924. PubMed DOI PMC

Akimoto A.K., Miranda-Vilela A.L., Alves P.C., Pereira L.C., Lordelo G.S., Hiragi C.d.O., da Silva I.C., Grisolia C.K., Klautau-Guimarães M.d.N. Evaluation of gene polymorphisms in exercise-induced oxidative stress and damage. Free Radic. Res. 2010;44:322–331. doi: 10.3109/10715760903494176. PubMed DOI

Demirbağ R., Yilmaz R., Güzel S., Celik H., Koçyigit A., Ozcan E. Effects of treadmill exercise test on oxidative/antioxidative parameters and DNA damage. Anadolu Kardiyol. Derg. 2006;6:135–140. PubMed

Bloomer R.J., Goldfarb A.H., McKenzie M.J. Oxidative stress response to aerobic exercise: Comparison of antioxidant supplements. Med. Sci. Sports Exerc. 2006;38:1098–1105. doi: 10.1249/01.mss.0000222839.51144.3e. PubMed DOI

Mrakic-Sposta S., Gussoni M., Moretti S., Pratali L., Giardini G., Tacchini P., Dellanoce C., Tonacci A., Mastorci F., Borghini A., et al. Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques. PLoS ONE. 2015;10:e0141780. doi: 10.1371/journal.pone.0141780. PubMed DOI PMC

Williamson J., Hughes C.M., Cobley J.N., Davison G.W. The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage. Redox Biol. 2020;36:101673. doi: 10.1016/j.redox.2020.101673. PubMed DOI PMC

Turner J.E., Hodges N.J., Bosch J.A., Aldred S. Prolonged depletion of antioxidant capacity after ultraendurance exercise. Med. Sci. Sports Exerc. 2011;43:1770–1776. doi: 10.1249/MSS.0b013e31821240bb. PubMed DOI

Vezzoli A., Dellanoce C., Mrakic-Sposta S., Montorsi M., Moretti S., Tonini A., Pratali L., Accinni R. Oxidative Stress Assessment in Response to Ultraendurance Exercise: Thiols Redox Status and ROS Production according to Duration of a Competitive Race. Oxid. Med. Cell. Longev. 2016;2016:6439037. doi: 10.1155/2016/6439037. PubMed DOI PMC

Mohammadjafari H., Arazi H., Nemati N., Bagherpoor T., Suzuki K. Acute Effects of Resistance Exercise and the Use of GH or IGF-1 Hormones on Oxidative Stress and Antioxidant Markers in Bodybuilders. Antioxidants. 2019;8:587. doi: 10.3390/antiox8120587. PubMed DOI PMC

Arazi H., Khanmohammadi A., Asadi A., Haff G.G. The effect of resistance training set configuration on strength, power, and hormonal adaptation in female volleyball players. Appl. Physiol. Nutr. Metab. 2018;43:154–164. doi: 10.1139/apnm-2017-0327. PubMed DOI

Zainudin H., Caszo B.A., Knight V.F., Gnanou J.V. Training Induced Oxidative Stress-Derived DNA and Muscle Damage in Triathletes. Eurasian J. Med. 2019;51:116–120. doi: 10.5152/eurasianjmed.2019.18106. PubMed DOI PMC

Bloomer R.J. Effect of exercise on oxidative stress biomarkers. Adv. Clin. Chem. 2008;46:1–50. doi: 10.1016/s0065-2423(08)00401-0. PubMed DOI

Gargallo P., Colado J.C., Juesas A., Hernando-Espinilla A., Estañ-Capell N., Monzó-Beltran L., García-Pérez P., Cauli O., Sáez G.T. The Effect of Moderate- Versus High-Intensity Resistance Training on Systemic Redox State and DNA Damage in Healthy Older Women. Biol. Res. Nurs. 2018;20:205–217. doi: 10.1177/1099800417753877. PubMed DOI

Vezzoli A., Pugliese L., Marzorati M., Serpiello F.R., La Torre A., Porcelli S. Time-course changes of oxidative stress response to high-intensity discontinuous training versus moderate-intensity continuous training in masters runners. PLoS ONE. 2014;9:e87506. doi: 10.1371/journal.pone.0087506. PubMed DOI PMC

Dimauro I., Sgura A., Pittaluga M., Magi F., Fantini C., Mancinelli R., Sgadari A., Fulle S., Caporossi D. Regular exercise participation improves genomic stability in diabetic patients: An exploratory study to analyse telomere length and DNA damage. Sci. Rep. 2017;7:4137. doi: 10.1038/s41598-017-04448-4. PubMed DOI PMC

Pittaluga M., Sgadari A., Dimauro I., Tavazzi B., Parisi P., Caporossi D. Physical exercise and redox balance in type 2 diabetics: Effects of moderate training on biomarkers of oxidative stress and DNA damage evaluated through comet assay. Oxid. Med. Cell. Longev. 2015;2015:981242. doi: 10.1155/2015/981242. PubMed DOI PMC

Toljic M., Egic A., Munjas J., Karadzov Orlic N., Milovanovic Z., Radenkovic A., Vuceljic J., Joksic I. Increased oxidative stress and cytokinesis-block micronucleus cytome assay parameters in pregnant women with gestational diabetes mellitus and gestational arterial hypertension. Reprod. Toxicol. 2017;71:55–62. doi: 10.1016/j.reprotox.2017.04.002. PubMed DOI

Ravassa S., Beaumont J., Huerta A., Barba J., Coma-Canella I., González A., López B., Díez J. Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study. Free Radic. Biol. Med. 2015;81:1–12. doi: 10.1016/j.freeradbiomed.2015.01.002. PubMed DOI

Al-Aubaidy H.A., Jelinek H.F. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010;15:155–160. doi: 10.1179/174329210X12650506623681. PubMed DOI PMC

Ye X., Jiang R., Zhang Q., Wang R., Yang C., Ma J., Du H. Increased 8-hydroxy-2′-deoxyguanosine in leukocyte DNA from patients with type 2 diabetes and microangiopathy. J. Int. Med. Res. 2016;44:472–482. doi: 10.1177/0300060515621530. PubMed DOI PMC

Negishi H., Ikeda K., Kuga S., Noguchi T., Kanda T., Njelekela M., Liu L., Miki T., Nara Y., Sato T., et al. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J. Hypertens. 2001;19:529–533. doi: 10.1097/00004872-200103001-00002. PubMed DOI

Xu G.W., Yao Q.H., Weng Q.F., Su B.L., Zhang X., Xiong J.H. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. J. Pharm. Biomed. Anal. 2004;36:101–104. doi: 10.1016/j.jpba.2004.04.016. PubMed DOI

Lorenzi M., Montisano D.F., Toledo S., Wong H.C. Increased single strand breaks in DNA of lymphocytes from diabetic subjects. J. Clin. Investig. 1987;79:653–656. doi: 10.1172/JCI112863. PubMed DOI PMC

Arif M., Islam M.R., Waise T.M., Hassan F., Mondal S.I., Kabir Y. DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients. Diabetes Metab. 2010;36:51–57. doi: 10.1016/j.diabet.2009.05.007. PubMed DOI

Manfredini V., Biancini G.B., Vanzin C.S., Dal Vesco A.M., Cipriani F., Biasi L., Treméa R., Deon M., Peralba M.d.C.R., Wajner M., et al. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients. Cell Biochem. Funct. 2010;28:360–366. doi: 10.1002/cbf.1654. PubMed DOI

Urbaniak S.K., Boguszewska K., Szewczuk M., Kaźmierczak-Barańska J., Karwowski B.T. 8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development. Molecules. 2020;25:202. doi: 10.3390/molecules25010202. PubMed DOI PMC

Chen Y.L., Chen K.H., Yin T.C., Huang T.H., Yuen C.M., Chung S.Y., Sung P.H., Tong M.S., Chen C.H., Chang H.W., et al. Extracorporeal shock wave therapy effectively prevented diabetic neuropathy. Am. J. Transl. Res. 2015;7:2543–2560. PubMed PMC

Jin Y., Qiu C., Zheng Q., Liu L., Liu Z., Wang Y. Efficacy of different doses of atorvastatin treatment on serum levels of 8-hydroxy-guanin (8-OHdG) and cardiac function in patients with ischemic cardiomyopathy. Pak. J. Med. Sci. 2015;31:37–42. doi: 10.12669/pjms.311.5840. PubMed DOI PMC

Inoue T., Inoue K., Maeda H., Takayanagi K., Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin. Chim. Acta. 2001;305:115–121. doi: 10.1016/S0009-8981(00)00426-5. PubMed DOI

Donmez-Altuntas H., Bayram F., Coskun-Demirkalp A.N., Baspınar O., Kocer D., Toth P.P. Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients. Exp. Biol. Med. 2019;244:1089–1095. doi: 10.1177/1535370219871895. PubMed DOI PMC

Ruan X.H., Ma T., Fan Y. Ablation of TMEM126B protects against heart injury via improving mitochondrial function in high fat diet (HFD)-induced mice. Biochem. Biophys. Res. Commun. 2019;515:636–643. doi: 10.1016/j.bbrc.2019.05.084. PubMed DOI

Sini S., Deepa D., Harikrishnan S., Jayakumari N. Adverse effects on macrophage lipid transport and survival by high density lipoprotein from patients with coronary heart disease. J. Biochem. Mol. Toxicol. 2018;32:e22192. doi: 10.1002/jbt.22192. PubMed DOI

Jang Y., Kim J.Y., Kim O.Y., Lee J.E., Cho H., Ordovas J.M., Lee J.H. The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am. J. Clin. Nutr. 2004;80:832–840. doi: 10.1093/ajcn/80.4.832. PubMed DOI

Setayesh T., Mišík M., Langie S.A.S., Godschalk R., Waldherr M., Bauer T., Leitner S., Bichler C., Prager G., Krupitza G., et al. Impact of Weight Loss Strategies on Obesity-Induced DNA Damage. Mol. Nutr. Food. Res. 2019;63:e1900045. doi: 10.1002/mnfr.201900045. PubMed DOI PMC

Setayesh T., Nersesyan A., Mišík M., Noorizadeh R., Haslinger E., Javaheri T., Lang E., Grusch M., Huber W., Haslberger A., et al. Gallic acid, a common dietary phenolic protects against high fat diet induced DNA damage. Eur. J. Nutr. 2019;58:2315–2326. doi: 10.1007/s00394-018-1782-2. PubMed DOI PMC

Setayesh T., Nersesyan A., Mišík M., Ferk F., Langie S., Andrade V.M., Haslberger A., Knasmüller S. Impact of obesity and overweight on DNA stability: Few facts and many hypotheses. Mutat. Res. Rev. Mutat. Res. 2018;777:64–91. doi: 10.1016/j.mrrev.2018.07.001. PubMed DOI

Demyanets S., Kaun C., Pfaffenberger S., Hohensinner P.J., Rega G., Pammer J., Maurer G., Huber K., Wojta J. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. Biochem. Pharmacol. 2006;71:1324–1330. doi: 10.1016/j.bcp.2006.01.016. PubMed DOI

Singh S., Nguyen H., Michels D., Bazinet H., Matkar P.N., Liu Z., Esene L., Adam M., Bugyei-Twum A., Mebrahtu E., et al. BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis. Physiol. Rep. 2020;8:e14481. doi: 10.14814/phy2.14481. PubMed DOI PMC

Wang Y.C., Lee A.S., Lu L.S., Ke L.Y., Chen W.Y., Dong J.W., Lu J., Chen Z., Chu C.S., Chan H.C., et al. Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo. Aging Cell. 2018;17:e12792. doi: 10.1111/acel.12792. PubMed DOI PMC

Lee A.S., Chen W.Y., Chan H.C., Hsu J.F., Shen M.Y., Chang C.M., Bair H., Su M.J., Chang K.C., Chen C.H. Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL. Cardiovasc. Diabetol. 2014;13:64. doi: 10.1186/1475-2840-13-64. PubMed DOI PMC

Jang Y., Kim O.Y., Ryu H.J., Kim J.Y., Song S.H., Ordovas J.M., Lee J.H. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J. Lipid Res. 2003;44:2356–2364. doi: 10.1194/jlr.M300233-JLR200. PubMed DOI

Włodarczyk M., Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Int. J. Mol. Sci. 2019;20:1146. doi: 10.3390/ijms20051146. PubMed DOI PMC

Włodarczyk M., Nowicka G. DNA damage, obesity and obesity-related health complications: What are new data telling us? Curr. Opin. Clin. Nutr. Metab. Care. 2024;27:325–330. doi: 10.1097/MCO.0000000000001038. PubMed DOI

Włodarczyk M., Jabłonowska-Lietz B., Olejarz W., Nowicka G. Anthropometric and Dietary Factors as Predictors of DNA Damage in Obese Women. Nutrients. 2018;10:578. doi: 10.3390/nu10050578. PubMed DOI PMC

Włodarczyk M., Ciebiera M., Nowicka G. TNF-α G-308A genetic variants, serum CRP-hs concentration and DNA damage in obese women. Mol. Biol. Rep. 2020;47:855–866. doi: 10.1007/s11033-019-04764-0. Erratum in Mol. Biol. Rep. 2019, 46, 3613. https://doi.org/10.1007/s11033-019-04835-2 . PubMed DOI PMC

Bankoglu E.E., Gerber J., Kodandaraman G., Seyfried F., Stopper H. Influence of bariatric surgery induced weight loss on oxidative DNA damage. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2020;853:503194. doi: 10.1016/j.mrgentox.2020.503194. PubMed DOI

Bankoglu E.E., Seyfried F., Arnold C., Soliman A., Jurowich C., Germer C.T., Otto C., Stopper H. Reduction of DNA damage in peripheral lymphocytes of obese patients after bariatric surgery-mediated weight loss. Mutagenesis. 2018;33:61–67. doi: 10.1093/mutage/gex040. PubMed DOI

Bankoglu E.E., Seyfried F., Rotzinger L., Nordbeck A., Corteville C., Jurowich C., Germer C.T., Otto C., Stopper H. Impact of weight loss induced by gastric bypass or caloric restriction on oxidative stress and genomic damage in obese Zucker rats. Free Radic. Biol. Med. 2016;94:208–217. doi: 10.1016/j.freeradbiomed.2016.02.033. PubMed DOI

Zaki M., Basha W., El-Bassyouni H.T., El-Toukhy S., Hussein T. Evaluation of DNA damage profile in obese women and its association to risk of metabolic syndrome, polycystic ovary syndrome and recurrent preeclampsia. Genes Dis. 2018;5:367–373. doi: 10.1016/j.gendis.2018.03.001. PubMed DOI PMC

Ibero-Baraibar I., Azqueta A., Lopez de Cerain A., Martinez J.A., Zulet M.A. Assessment of DNA damage using comet assay in middle-aged overweight/obese subjects after following a hypocaloric diet supplemented with cocoa extract. Mutagenesis. 2015;30:139–146. doi: 10.1093/mutage/geu056. PubMed DOI

Jones D.A., Prior S.L., Barry J.D., Caplin S., Baxter J.N., Stephens J.W. Changes in markers of oxidative stress and DNA damage in human visceral adipose tissue from subjects with obesity and type 2 diabetes. Diabetes Res. Clin. Pract. 2014;106:627–633. doi: 10.1016/j.diabres.2014.09.054. PubMed DOI

Remely M., Ferk F., Sterneder S., Setayesh T., Kepcija T., Roth S., Noorizadeh R., Greunz M., Rebhan I., Wagner K.H., et al. Vitamin E Modifies High-Fat Diet-Induced Increase of DNA Strand Breaks, and Changes in Expression and DNA Methylation of Dnmt1 and MLH1 in C57BL/6J Male Mice. Nutrients. 2017;9:607. doi: 10.3390/nu9060607. PubMed DOI PMC